Simcere Garners European Approval for Diarrhea Drug

Simcere Pharma (先声药业) reported that diosmectite, the API in its branded generic diarrhea drug Biqi, has passed EU-GMP inspection. Diosmectite is made from a natural mineral, and Simcere owns a high-grade diosmectite mine in China. It is the leading anti-diarrhea drug in China and France. More details... Stock Symbol: (NYSE: SCR)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.